Andrea Aslan, MD
Obstetrics/Gynecology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Aslan’s office at (650) 903-3000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A81102 · Current
Licensed to practise in California · since 2002 · expires 2028-02-29 · Northwestern University Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$19,973
Pharmacies billed $19,973 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
248 generic and 23 brand-name prescriptions · $19,973 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Yuvafem | 65 | $6,847 | $105 |
| Estradiol | 66 | $2,695 | $41 |
| Acyclovir | 12 | $254 | $21 |
| Alendronate | 12 | $118 | $10 |
Year by year
| 2024 | 271 | 100 | None | 8% | $19,973 |
| 2023 | 319 | 118 | 0% (0) | 10% | $26,755 |
| 2022 | 299 | 108 | None | 10% | $26,557 |
| 2021 | 284 | 96 | None | 13% | $23,978 |
| 2020 | 265 | 98 | 0% (0) | 19% | $24,835 |
| 2019 | 241 | 85 | None | 19% | $25,677 |
| 2018 | 232 | 78 | None | 25% | $22,671 |
| 2017 | 226 | 80 | 0% (0) | 31% | $28,125 |
| 2016 | 210 | 76 | None | 35% | $26,263 |
| 2015 | 216 | 74 | None | 37% | $25,687 |
| 2014 | 255 | 79 | 0% (0) | 42% | $25,341 |
| 2013 | 280 | 81 | None | 41% | $21,405 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Yuvafem | 87 | $10,385 | $119 |
| Estradiol | 72 | $2,720 | $38 |
| Acyclovir | 12 | $300 | $25 |
| Medroxyprogesterone Acetate | 13 | $240 | $18 |
| Triamcinolone Acetonide | 13 | $148 | $11 |
| Alendronate | 14 | $145 | $10 |
2022: 6 drugs
| Yuvafem | 63 | $9,334 | $148 |
| Estring | 11 | $6,220 | $565 |
| Estradiol | 69 | $2,284 | $33 |
| Medroxyprogesterone Acetate | 17 | $302 | $18 |
| Alendronate | 15 | $156 | $10 |
| Triamcinolone Acetonide | 12 | $112 | $9 |
2021: 7 drugs
| Estradiol | 90 | $5,896 | $66 |
| Yuvafem | 30 | $4,210 | $140 |
| Climara | 13 | $2,027 | $156 |
| Acyclovir | 12 | $339 | $28 |
| Medroxyprogesterone Acetate | 18 | $284 | $16 |
| Alendronate | 12 | $125 | $10 |
| Triamcinolone Acetonide | 13 | $96 | $7 |
2020: 5 drugs
| Estradiol | 100 | $8,268 | $83 |
| Estring | 12 | $6,424 | $535 |
| Climara | 12 | $1,764 | $147 |
| Medroxyprogesterone Acetate | 23 | $395 | $17 |
| Acyclovir | 13 | $344 | $26 |
2019: 6 drugs
| Estring | 13 | $6,615 | $509 |
| Yuvafem | 11 | $3,321 | $302 |
| Estradiol | 71 | $3,088 | $43 |
| Climara | 13 | $2,007 | $154 |
| Medroxyprogesterone Acetate | 25 | $494 | $20 |
| Acyclovir | 18 | $257 | $14 |
2018: 6 drugs
| Estring | 12 | $5,819 | $485 |
| Estrace | 35 | $4,283 | $122 |
| Yuvafem | 11 | $2,128 | $193 |
| Estradiol | 49 | $1,657 | $34 |
| Medroxyprogesterone Acetate | 28 | $709 | $25 |
| Acyclovir | 14 | $331 | $24 |
2017: 6 drugs
| Estrace | 30 | $9,263 | $309 |
| Estring | 11 | $4,798 | $436 |
| Premarin | 11 | $4,226 | $384 |
| Estradiol | 52 | $1,372 | $26 |
| Medroxyprogesterone Acetate | 31 | $867 | $28 |
| Hydrocortisone | 13 | $155 | $12 |
2016: 4 drugs
| Estrace | 38 | $10,840 | $285 |
| Estring | 12 | $4,441 | $370 |
| Estradiol | 44 | $1,445 | $33 |
| Medroxyprogesterone Acetate | 30 | $620 | $21 |
2015: 6 drugs
| Estrace | 27 | $6,510 | $241 |
| Premarin | 17 | $5,377 | $316 |
| Estring | 11 | $3,363 | $306 |
| Estradiol | 50 | $1,549 | $31 |
| Medroxyprogesterone Acetate | 29 | $591 | $20 |
| Acyclovir | 12 | $486 | $40 |
2014: 5 drugs
| Premarin | 27 | $6,688 | $248 |
| Estrace | 29 | $6,030 | $208 |
| Progesterone | 16 | $3,194 | $200 |
| Estradiol | 72 | $1,451 | $20 |
| Medroxyprogesterone Acetate | 43 | $853 | $20 |
2013: 5 drugs
| Premarin | 22 | $3,818 | $174 |
| Estrace | 17 | $3,257 | $192 |
| Progesterone | 15 | $2,909 | $194 |
| Estradiol | 82 | $1,759 | $21 |
| Medroxyprogesterone Acetate | 48 | $947 | $20 |
Money from drug and device companies
$19 in 2025
| 2025 | 1 | 1 | None | $19 |
| 2024 | 1 | 2 | None | $39 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| TG Therapeutics | Briumvi | $19 | 1 payment
|
See the published payment
| TG Therapeutics | Meals · 2025-10-09 | Briumvi | $19 |
See earlier years (2024)
2024: $39
| TG Therapeutics | Briumvi | $39 | 2 payments
|
Professional record
- NPI
- 1104903046
- Licence
- CA A81102California A81102: Current · expires 2028-02-29
- Trained
- Northwestern University Feinberg Medical School, 1994
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A811020
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 1800 Harrison St Fl 7, Oakland, CA, 94612
- NPI first listed
- 2006-10-31
- NPI last updated
- 2021-12-08
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.